ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹23 Cr | ₹20 Cr | ₹26 Cr | ₹32 Cr | ₹34 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹34 Cr |
How is Deferred Tax Assets / Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | 16.96 | |
| Mar2024 | ₹20 Cr | -22.57 | |
| Mar2023 | ₹26 Cr | -18.68 | |
| Mar2022 | ₹32 Cr | -6.33 | |
| Mar2021 | ₹34 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹4,076.2 Cr | -6.8% | 20.6% | 23.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -6.8% |
20.6% |
23.1% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses